Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

100%

3 of 3 completed trials have results

Key Signals

1 recruiting3 with results

Enrollment Performance

Analytics

N/A
4(100.0%)
4Total
N/A(4)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT07637500Not ApplicableRecruiting

Refocus VisAbility™ Micro Insert System Pre-market Clinical Trial

Role: lead

NCT03811249Not ApplicableCompleted

Long Term Follow-up of the VisAbility™ Micro Insert System for Presbyopic Patients

Role: lead

NCT02374671Not ApplicableCompleted

A Clinical Trial of The VisAbility Micro Insert System for Presbyopic Patients

Role: lead

NCT01166568Not ApplicableCompleted

Trial of the PresVIEW Implant for the Improvement of Near Vision in Patients With Presbyopia

Role: lead

All 4 trials loaded